Research Review By Dr. Jeff Muir©

Audio:

Download MP3

Date Posted:

May 2018

Study Title:

Red flag screening for low back pain: nothing to see here, move along: a narrative review

Authors:

Cook CE, George SZ & Reiman MP

Author's Affiliations:

Division of Physical Therapy, Duke MSK, Duke Clinical Research Institute, Durham, North Carolina, USA; Department of Orthopaedic Surgery, Duke University, Durham, North Carolina, USA.

Publication Information:

British Journal of Sports Medicine 2018; 52: 493–496.

Background Information:

Diagnosis remains a necessary and important component of patient care and, despite training, background or philosophy, clinicians who treat low back pain (LBP) use differential diagnostics to improve the likelihood of providing the appropriate care to the patient. Among the differential diagnostic techniques generally employed by clinicians is screening for potentially significant conditions, first termed red flag screening by Berry (1). Berry was a proponent of preliminary screening for signs or symptoms related to serious underlying pathology, suggesting that identification of such red flags was valuable in that it may indicate the need for more diagnostic testing before treatment is delivered. Ninety years after Berry suggested their use, researchers have concluded that screening for red flags associated with low back pain does not work. In this review, the authors outline where this process is lacking and offer alternatives to consider in the future of low back pain management.

Summary:

The authors propose the following reasons why red flag screening does not work:

Reason 1: red flag symptoms neither rule out nor identify serious pathology
The likelihood ratio (LR) of a test ruling in or out a condition is calculated using the sensitivity and specificity values from a contingency table. A negative LR (-LR), or the probability of a person who has a disease and tests negative over the probability of a person who does not have a disease testing negative, is used to rule out a condition, with the strength of the finding increasing as the -LR approaches 0. Conversely, a +LR, or the probability of a person who has a disease and tests positive over the probability of a person who does not have a disease testing positive. The +LR rules in a disease or condition, with a higher +LR (i.e. closer to 1.0) more strongly ruling a condition in. The value of these indicators; however, is minimal. In a meta-analysis, Downie et al. (2) demonstrated that tests for red flags are insufficient in ruling out a condition via negative findings. Similarly, Williams et al. (3) tested red flag screening for vertebral fracture in LBP patients and found that the post-test probability for ruling out fractures improved by less than 1% when a negative finding on red flag testing occurs.

Reason 2: variability in definitions for red flag symptoms greatly limits research and clinical progress in this area
Due to the low prevalence of serious conditions, studies evaluating symptoms and tests for red flags are very difficult to conduct, owing to the prohibitively large sample sizes that are required when properly powering studies. As a result, inconsistency in the assessment of red flags continues. In a systematic review attempting to identify types of red flag symptomatology (4), 97 unique items representing symptoms from eight body systems were identified, with 10 items needed to identify a red flag responder with 94.7% accuracy and 23 items required to identify with 100% certainty. This variability limits the ability of red flag screening to properly identify underlying conditions.

Reason 3: LBP guidelines do not help
The vast majority of guidelines for treatment of low back pain endorse the use of red flag screening for determining the presence of spinal fracture or malignancy (5). However, an overview of guidelines for non-specific LBP revealed 8 guidelines endorsing 27 red flags for malignancy and 26 for fracture, although none of the 8 guidelines endorsed the same set of red flags (6). As such, no stable nor consistent set of rules exists for clinicians to use to identify possible underlying conditions. Additionally, the use of traditional red flags for imaging (age < 45, night/morning pain, family history, etc.) can lead to significant overuse of imaging and potentially inappropriate clinical reasoning (7).

Reason 4: clinicians do not actually screen for red flags; they manage LBP conditions they see
Medical screening seeks to identify signs and symptoms of a condition in an asymptomatic patient population, while diagnostic testing involves clinical procedures to aid in the detection or diagnosis of a suspected disease or condition. Low back pain is itself a symptom of an underlying condition and not a diagnosis. It is not affiliated with a serious pathology and will often exhibit symptoms similar to competing diagnoses such as fracture or cancer. Many red flags associated with LBP are more prevalent in an older population, which also frequently have concomitant orthopaedic-related LBP (8). Indeed, a definitive set of signs and symptoms that are unique to serious pathology of the low back has not been identified, whether for screening or diagnostic purposes.

Clinical Application & Conclusions:

The authors offer 3 recommendations regarding testing for red flags:
  1. Watchful waiting: rather than ordering early diagnostic testing, clinicians are encouraged to use watchful waiting, or the act of close surveillance, while allowing time to pass before initiating medical intervention. Early testing may, in fact, be detrimental to patients with LBP (9). As well, early detection may increase the incidence of several diseases but for many, the mortality rate remains unchanged (10). As such, the usefulness of early detection may not be justified. The authors recommend careful monitoring of symptoms, watching for changes over time.
  2. Value-based care: the costs associated with the episode of care for LBP can escalate rapidly when diagnostic imaging such as MRI are incorporated, which can significantly affect the value-based aspects of care. The authors advocate for the careful use of such tests and recommend adopting careful consideration of value-based care before ordering expensive and potentially unnecessary tests.
  3. Link red flag testing with health status rather than diagnostic testing: up to 94% of patients presenting to a general practice will present with abnormal MRI findings, while only 3% are likely to have an underlying serious pathology (11). In fact, the serious condition most likely to be present in this population is vertebral fracture, for which there are reliable clinical tests. Linking tests to the patient’s health status, rather than potential red flags, could lead to a decrease in the use of diagnostic imaging, and an overall improvement in the episode of care.

Study Methods:

These authors presented a narrative review, using clinical experience and comprehensive literature reviews to compile their recommendations.

Study Strengths / Weaknesses:

Strengths:
  • Comprehensive review making good use of clinical guidelines, systematic reviews and relevant clinical evidence.
  • The author group has strong and relevant clinical experience.
Weaknesses:
  • As this was a narrative review, the authors were not able to pool data to help support findings or recommendations.

Additional References:

  1. Berry JM. Painful conditions in the lumbar, lumbosacral and sacro-iliac regions. Arch Surg 1925 archsurg.jamanetwork.com.
  2. Downie A, Williams CM, Henschke N, et al. Red flags to screen for malignancy and fracture in patients with low back pain: systematic review. BMJ 2013; 347: f7095.
  3. Williams CM, Henschke N, Maher CG, et al. Red flags to screen for vertebral fracture in patients presenting with low-back pain. Cochrane Database Syst Rev 2013: CD008643.
  4. George SZ, Beneciuk JM, Bialosky JE, et al. Development of a review-of-systems screening tool for orthopaedic physical therapists: results from the optimal screening for prediction of referral and outcome (OSPRO) cohort. J Orthop Sports Phys Ther 2015; 45: 512–26.
  5. O’Connell NE, Cook CE, Wand BM, et al. Clinical guidelines for low back pain: A critical review of consensus and inconsistencies across three major guidelines. Best Pract Res Clin Rheumatol 2016; 30(6): 968-980. doi: 10.1016/j.berh.2017.05.001.
  6. Koes BW, van Tulder M, Lin CW, et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J 2010; 19: 2075–94.
  7. Negrini S, Giovannoni S, Minozzi S, et al. Diagnostic therapeutic flow-charts for low back pain patients: the Italian clinical guidelines. Eura Medicophys 2006; 42: 151–70.
  8. Cook C, Ross MD, Isaacs R, et al. Investigation of nonmechanical findings during spinal movement screening for identifying and/or ruling out metastatic cancer. Pain Pract 2012; 12: 426–33.
  9. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet 2015; 385: 117–71.
  10. Saquib N, Saquib J, Ioannidis JP. Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials. Int J Epidemiol 2015; 44: 264–77.
  11. Joines JD, McNutt RA, Carey TS, et al. Finding cancer in primary care outpatients with low back pain: a comparison of diagnostic strategies. J Gen Intern Med 2001; 16: 14–23.